Revolution Medicines- Warrants (17/12/2026) Total Liabilities

As of the most recent data (September 2026), RVMDW shows a total liabilities of $1.9B. That compares with $660M in the prior-year period — up 190.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RVMDW's total liabilities is now $1.9B (was $660M) — a 190.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Revolution Medicines- Warrants (17/12/2026) is outperforming or lagging.

Tracking RVMDW's total liabilities over time shows whether Revolution Medicines- Warrants (17/12/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.9B That compares with $660M in the prior-year period — up 190.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Revolution Medicines- Warrants (17/12/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $1.9B) with ownership activity and broader fundamentals.

Revolution Medicines- Warrants (17/12/2026)'s total liabilities is $1.9B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.